Patent details

EP2526928 Title: Increased effectiveness of allylamine drug compounds

Basic Information

Publication number:
EP2526928
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP121696587
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Increased effectiveness of allylamine drug compounds
French Title of Invention:
Efficacité accrue de composés médicamenteux d'allylamine
German Title of Invention:
Erhöhte Effektivität von Allylamin-Heilmittelverbindungen
SPC Number:

Dates

Filing date:
05/02/2008
Grant date:
26/12/2018
EP Publication Date:
28/11/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/12/2018
EP B1 Publication Date:
26/12/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/02/2019
Expiration date:
05/02/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/12/2018
 
 

Name:
Biophile Corporation, Ltd
Address:
884-886 Ploenchit Road Lumpinee Patumwan, Bankok 10330, Thailand (TH)

Inventor

1

Name:
Vayumhasuwan, Panida
Address:
Thailand (TH)

2

Name:
Suvanprakorn, Pichit
Address:
Thailand (TH)

3

Name:
Zaias, Nardo
Address:
United States (US)

Priority

Priority Number:
89943307 P
Priority Date:
05/02/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/06; A61K 31/131; A61K 31/137; A61P 31/10;

Publication

European Patent Bulletin

Issue number:
201852
Publication date:
26/12/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages